Hot Stocks: Windstream Holdings, Inc. (NASDAQ:WIN), SolarCity Corp (NASDAQ:SCTY), Weibo Corp (ADR) (NASDAQ:WB), MeetMe Inc. (NASDAQ:MEET), Medical Marijuana Inc. (OTCMKTS:MJNA)

Zacks reiterated their neutral rating on shares of Windstream Holdings Inc. (NASDAQ:WIN) in a research report released on Wednesday morning. Zacks currently has a $10.00 price objective on the stock. Windstream Holdings, Inc. (NASDAQ:WIN) net profit margin is 3.40% and weekly performance is 0.83%. On last trading day company shares ended up $9.67. Analysts mean target price for the company is $8.91. Windstream Holdings, Inc. (NASDAQ:WIN) distance from 50-day simple moving average (SMA50) is 6.54%.

What was supposed to bring joy to the U.S. solar sector is already generating more heat than light for companies such as SolarCity Corp (NASDAQ:SCTY). Solar Energy Industries Association (SEIA) believes the future of the solar industry in the U.S. is bleak under the high taxes on Chinese solar imports. SolarCity Corp (NASDAQ:SCTY) shares fell -0.87% in last trading session and ended the day on $49.19. SCTY gross Margin is 23.60% and its return on assets is -1.70%.SolarCity Corp (NASDAQ:SCTY) quarterly performance is -32.94%.

Weibo Corp (ADR) (NASDAQ:WB) was gaining 3.1% to $19.23 Tuesday after Credit Suisse initiated coverage of the company. Weibo Corp (ADR) (NASDAQ:WB) shares moved up 1.39% in last trading session and was closed at $18.91, while trading in range of $18.80 – $19.96. Weibo Corp (ADR) (NASDAQ:WB) year to date (YTD) performance is -6.57%.

MeetMe, Inc. (NASDAQ:MEET), the public market leader in social discovery, on 8 may reported financial results for the first quarter ended March 31, 2014. Total revenue was $9.5 million, up 22% from the first quarter of 2013. MeetMe Inc. (NASDAQ:MEET) ended the last trading day at $1.84. Company weekly volatility is calculated as 4.25% and price to cash ratio as 12.25.MeetMe Inc. (NASDAQ:MEET) showed a negative weekly performance of -1.08%.

Medical marijuana Inc. (OTCMKTS:MJNA) is promising for sickle cell patients because it has a pain-relieving effect without as many severe side effects as morphine, Simone said. On last trading day company shares ended up $0.209.